Institutional Ownership Harmony Biosciences Holdings, Inc. (HRMY)
This table provides information about the institutional ownership of Harmony Biosciences Holdings, Inc. (HRMY). We have compiled data on the 318 institutions that hold shares in the stock, with a total of 42.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.46 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,835,243
shares
|
$199 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.48%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
5,097,176
shares
|
$173 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.27%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
1,691,581
shares
|
$57.6 Million
0.01% of portfolio
|
Q3 2025
Added 6.91%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
1,669,565
shares
|
$56.8 Million
0.02% of portfolio
|
Q3 2025
Added 11.2%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,653,604
shares
|
$56.3 Million
0.0% of portfolio
|
Q3 2025
Added 1.5%
|
|
|
Lsv Asset Management
Chicago, IL |
Nov 06, 2025 Q3 2025 |
1,594,893
shares
|
$54.3 Million
0.1% of portfolio
|
Q3 2025
Added 7.15%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
1,295,381
shares
|
$44.1 Million
0.02% of portfolio
|
Q3 2025
Added 42.83%
|
|
|
Valor Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,268,204
shares
|
$43.2 Million
52.7% of portfolio
|
Q3 2025
Reduced 80.84%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,258,263
shares
|
$42.8 Million
0.0% of portfolio
|
Q3 2025
Added 19.34%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2025 Q3 2025 |
1,137,071
shares
|
$38.7 Million
0.04% of portfolio
|
Q3 2025
Added 22.34%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
847,895
shares
|
$28.9 Million
0.0% of portfolio
|
Q3 2025
Added 11.73%
|
|
|
Boston Partners
Boston, MA |
Nov 13, 2025 Q3 2025 |
753,952
shares
|
$25.7 Million
0.02% of portfolio
|
Q3 2025
Added 24.52%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
646,653
shares
|
$22 Million
0.0% of portfolio
|
Q3 2025
Reduced 10.27%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Oct 29, 2025 Q3 2025 |
570,539
shares
|
$19.4 Million
0.01% of portfolio
|
Q3 2025
Reduced 11.48%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
503,081
shares
|
$17.1 Million
0.0% of portfolio
|
Q3 2025
Added 213.3%
|
|
|
Ven Bio Partners LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
489,194
shares
|
$16.6 Million
9.17% of portfolio
|
Q1 2025
Reduced 9.27%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
456,401
shares
|
$15.5 Million
0.0% of portfolio
|
Q3 2025
Added 4.24%
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Nov 14, 2025 Q3 2025 |
437,163
shares
|
$14.9 Million
0.02% of portfolio
|
Q3 2025
Added 3.37%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
432,761
shares
|
$14.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.27%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
425,701
shares
|
$14.5 Million
0.0% of portfolio
|
Q3 2025
Added 89.06%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
403,288
shares
|
$13.7 Million
0.0% of portfolio
|
Q3 2025
Added 0.58%
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Oct 15, 2025 Q3 2025 |
362,948
shares
|
$12.4 Million
0.03% of portfolio
|
Q3 2025
Reduced 4.53%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
355,568
shares
|
$12.1 Million
0.01% of portfolio
|
Q3 2025
Added 133.88%
|
|
|
Capital Management Corp
|
Nov 04, 2025 Q3 2025 |
322,912
shares
|
$11 Million
1.56% of portfolio
|
Q3 2025
Reduced 8.41%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
314,500
shares
|
$10.7 Million
3.5% of portfolio
|
Q3 2023
Reduced 44.87%
|
|